Absolute Capital Management LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 59.7% during the fourth quarter, Holdings Channel.com reports. The fund owned 19,639 shares of the exchange traded fund’s stock after acquiring an additional 7,339 shares during the quarter. Absolute Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $2,395,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also added to or reduced their stakes in XBI. Legacy Wealth Managment LLC ID purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $32,000. Greykasell Wealth Strategies Inc. purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $35,000. Ballast Advisors LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at approximately $36,000. Creative Financial Designs Inc. ADV purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $39,000. Finally, MCF Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $46,000.
SPDR S&P Biotech ETF Trading Up 3.0%
NYSEARCA:XBI opened at $132.74 on Friday. SPDR S&P Biotech ETF has a 12-month low of $80.90 and a 12-month high of $139.19. The stock has a 50-day moving average price of $132.53 and a 200 day moving average price of $127.08. The stock has a market capitalization of $8.47 billion, a P/E ratio of 11.47 and a beta of 0.85.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
